Cowen Investment Management’s Adit EdTech Acquisition Corp Units ADEX.U Stock Holding History

Cowen Investment Management’s Portfolio ADEX.U Stock Details ADEX.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100,000	Closed	-$987K	–	218
2022 Q3	$987K	Hold	100,000	–	–	0.21%	150
2022 Q2	$983K	Hold	100,000	–	–	0.21%	146
2022 Q1	$1.01M	Hold	100,000	–	–	0.22%	91
2021 Q4	$1.02M	Sell	100,000 -125,000	-56%	-$1.27M	0.22%	76
2021 Q3	$2.25K	Hold	225,000	–	–	﹤0.01%	30
2021 Q2	$2.25M	Buy	225,000 +100,000	+80%	+$997K	0.58%	17
2021 Q1	$1.23M	Buy	+125,000	New	+$1.28M	0.48%	37

Other funds holding ADEX.U

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Cowen Investment Management's ADEX.U Position: Q4 2022 in Review

Cowen Investment Management sold out of Adit EdTech Acquisition Corp Units (ADEX.U) in Q4 2022, closing a stake of 100,000 shares — an estimated $987K sold.

Cowen Investment Management first reported a position in ADEX.U in Q1 2021 and held it in 7 quarters. The position peaked at $2.25M in Q2 2021. 4 funds tracked by Wall St. Rank hold ADEX.U as of Q4 2022.

Cowen Investment Management reported no remaining Adit EdTech Acquisition Corp Units position as of Q4 2022 after selling out during the quarter.
Cowen Investment Management sold 100,000 Adit EdTech Acquisition Corp Units shares in Q4 2022, an estimated $987K.
Cowen Investment Management first reported a position in Adit EdTech Acquisition Corp Units in Q1 2021 and held it in 7 quarters.
Cowen Investment Management's Adit EdTech Acquisition Corp Units position peaked at $2.25M in Q2 2021.
4 funds tracked by Wall St. Rank held Adit EdTech Acquisition Corp Units as of Q4 2022.

Based on Cowen Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.